Artivion Inc traded at $19.10 this Friday November 13th, decreasing $0.30 or 1.55 percent since the previous trading session. Looking back, over the last four weeks, Artivion lost 11.29 percent. Over the last 12 months, its price fell by 58.21 percent. Looking ahead, we forecast Artivion Inc to be priced at 18.67 by the end of this quarter and at 17.44 in one year, according to Trading Economics global macro models projections and analysts expectations.
CryoLife, Inc. (CryoLife), is a medical device company. The Company is engaged in the manufacturing, processing, and distribution of medical devices and implantable human tissues used in cardiac and vascular surgical procedures for patients with aortic disease. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as Surgical Sealants, BioGlue products, JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PhotoFix, and NEXUS. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues.